Isaac Francis

The United Kingdom has moved closer to full crypto oversight after regulators published new operational guidance.

Boston-based Rhythm Pharmaceuticals (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on rare genetic diseases of obesity, announced preliminary, unaudited net product revenues for its flagship therapy IMCIVREE (setmelanotide) for the fourth quarter and full year ended December 31, 2025.

The Kroger Company (NYSE:KR) completed the sale of its online health-and-wellness subsidiary, Vitacost.com, to iHerb on Friday, a move aimed at excising non-core digital assets as the grocery giant narrows its focus on its primary retail operations and high-return business lines.

ChipMOS TECHNOLOGIES (NASDAQ:IMOS) reported a sharp rise in fourth-quarter revenue on Friday, as the specialized semiconductor packager benefits from a "perfect storm" of high-density memory demand and a strategic shift toward AI-related infrastructure.

Johnson & Johnson (NYSE:JNJ) became the latest pharmaceutical titan to bow to White House pressure, announcing a voluntary agreement to lower prescription drug costs in exchange for an exemption from the administration’s aggressive new import tariffs.

Nasa is ending an ISS mission early after one astronaut developed a serious medical condition.

Zerion has added TRON support to its wallet, expanding access to stablecoin payments and TRON-based assets.

BlackOpal is using blockchain to tokenise Brazilian credit card debt, giving merchants instant cash and investors double-digit returns.

Brale is bringing its enterprise-grade stablecoin issuance platform to the Algorand blockchain.

Boston Dynamics has launched its first commercially deployable Atlas humanoid robot at CES 2026.